Chimeric antigen receptor–T cell therapy manufacturing: modelling the effect of offshore production on aggregate cost of goods

Cell and gene therapies have demonstrated excellent clinical results across a range of indications with chimeric antigen receptor (CAR)–T cell therapies among the first to reach market. Although these therapies are currently manufactured using patient-derived cells, therapies using healthy donor cel...

Full description

Saved in:
Bibliographic Details
Main Authors: Richard Harrison, Ezequiel Zylberberg, Simon Ellison, Bruce L. Levine
Format: Default Article
Published: 2019
Online Access:
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items